Primary Dysmenorrhea. Primary dysmenorrhoea
Conditions
Interventions
Intervention 1: Intervention group 1: will receive handmade saffron capsule, 30 mg dried saffron powder, three times per day for three days of menstrual period for three consecutive menstural cycles.
Treatment - Drugs
Placebo
Intervention group 2: will receive mefenamic acid 250mg capsule (Amin Pharmaceuticals, Isfahan, Iran) three times per day for three days of menstrual period for three consecutive menstural cycles.
Intervention group 1: will receive handmade saffron capsule, 30 mg dried saffron powder, three times per day for three days of menstrual period for three consecutive menstural cycles.
Control group: will receive placebo capsule three times per day for three days of menstrual period for three consecutive menstural cycles.
Sponsors
No sponsor used
Eligibility
Sex/Gender
Female
Age
18 Years to 27 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria:primary dysmenorrhea; Not having asthma, GI problems, intolerance to NSAIDs; Age = 18-27 years; written informed consent. Exclusion criteria:pregnancy; allergy to herbal products including saffron
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 3rd day of menstural cycle. Method of measurement: Visual Analogue Scale (VAS) and Verbal Multidimensional Scoring system (VMS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRamin Abrishami
Islamic Azad University of Pharmaceutical Sciences
Outcome results
None listed